Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Staurosporine analog; PKC inhibitor.
Pyrimidine analog, fluorouracil derivative; thy...
Laminin-derived peptapeptide.
Organosulfur, antioxidant.
MEK1/2 inhibitor.
Dual kinase and GTPase inhibitor.
Endogenous peptide fragment, involved in vasoco...
β-adrenergic antagonist, voltage-gated Na+ and...
Chloroethylnitrosourea, DNA alkylator and cross...
Immunodominant peptide epitope occurring in mul...
Valsartan impurity
Flavanol originally found in Camilla (green tea...
AurKA/B inhibitor.
Tankyrase inhibitor.
Triterpene saponin found in Bupleurum.
Retinoid; RARα/β/γ agonist.
Trichothecene mycotoxin produced by Fusarium.
Steroid hormone involved in stress signaling; g...
Peptide, neurotensin analog.
Thienylbutyl ITC analog.